Inhibition of the HIV-1 Rev-RRE complex formation by unfused aromatic cations

Bioorganic and Medicinal Chemistry

Volumn 9, Issue 5, 2001, Pages 1097-1113

  Xiao, Ge ^a   Kumar, Arvind ^a   Li, Ke ^a   Rigl, C Ted ^a   Bajic, Miroslav ^a   Davis, Tina M ^a   Boykin, David W ^a   Wilson, W David ^a  

^a GEORGIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 [4 [N (3 N,N DIMETHYLAMINOPROPYL)AMIDINO] 2 BENZIMIDAZOLYL] 5 [[4 (3 N,N DIMETHYLAMINOPROPYL)AMIDINO]PHENYL]FURAN; 2 [5 (2 IMIDAZOLINYL) 2 BENZIMIDAZOLYL] 5 [4 (2 IMIDAZOLINYL)PHENYL]FURAN; 2,4 BIS[4 [N (3 DIMETHYLAMINOPROPYL)AMIDINO]PHENYL]PYRIMIDINE; 2,5 BIS 4 N (3 DIMETHYLAMINOPROPYL)AMIDINOPHENYLTHIOPHENE; 2,5 BIS[3 [N (3 DIMETHYLAMINOPROPYL)AMIDINO]]PHENYLFURAN; 2,5 BIS[4 [3 (N,N DIMETHYLAMINOPROPYL)CARBAMOYL]PHENYL]FURAN; 2,5 BIS[4 [N (3 DIMETHYLAMINOPROPYL)AMIDINO]PHENYL]OXAZOLE; 2,5 BIS[4 [N (3 N PYRROLIDINOPROPYL)AMIDINO]PHENYL]FURAN; 2,5 BIS[4 [N (3 N,N DIMETHYAMINOPROPYL)AMIDINO]PHENYL] 3 (4 TOLYLOXY)FURAN; 2,5 BIS[4 [N (4 DIMETHYLAMINOBUTYL)AMIDINO]PHENYL]FURAN; 2,5 BIS[4 [N (4 DIMETHYLAMINOPROPYL)AMIDINO]PHENYL] 3 METHYLFURAN; 2,5 BIS[4 [N (6 DIMETHYLAMINOHEXYL)AMIDINO]PHENYL]FURAN; 2,5 BIS[4 [N [3 (4 N METHYLPIPERAZINO)PROPYL]AMIDINO]PHENYL]FURAN; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CATION; DB 302; DB 316; DB 339; DB 340; DB 355; DB 378; DB 379; DB 380; DB 394; DB 400; DB 414; DB 436; DB 449; FURAN DERIVATIVE; REV PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; COMPLEX FORMATION; DNA RESPONSIVE ELEMENT; DRUG BINDING SITE; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN IMMUNODEFICIENCY VIRUS 1; PROTEIN DETERMINATION; REV RESPONSIVE ELEMENT; RNA BINDING; STRUCTURE ACTIVITY RELATION;

AMINOGLYCOSIDES; CATIONS; DRUG DESIGN; FURANS; GENE PRODUCTS, REV; GENES, ENV; HIV LONG TERMINAL REPEAT; HIV-1; MACROMOLECULAR SUBSTANCES; MODELS, BIOLOGICAL; PROTEIN DENATURATION;

EID: 0035015697     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(00)00344-8     Document Type: Article

References (42)

1. Tinoco I.J., Bustamanta C. J. Mol. Biol. 293:1999;271.
2. Gesteland, R. F.; Atkins, J. F., Eds. The RNA World II; Cold Spring Harbor Laboratory: Plainview, NY, 1993; 1-630.
3. Niedle, S., Eds. Oxford Handbook of Nucleic Acid Structure; Oxford University Press, Oxford, 1999; p 608.
4. Draper D.E. J. Mol. Biol. 293:1999;255.
5. Wong C.-H., Hendrix M., Manning D.D., Rosenbohm C., Greenberg W.A. J. Am. Chem. Soc. 120:1998;8319.
6. Hendrix M., Priestley E.S., Joyce G.F., Wong C.-H. J. Am. Chem. Soc. 119:1997;3641.
7. Sucheck S.J., Wong A.L., Koeller K.M., Boehr D.D., Draker K.-A., Sears P., Wright G.J., Wong C.-H. J. Am. Chem. Soc. 122:2000;5230.
8. Sucheck S.J., Greenberg W.A., Tolbert T.J., Wong C.-H. Angew. Chem., Int. Ed. 39:2000;1080.
9. Chow C.S., Bogdan F.M. Chem. Rev. 97:1997;1489.
10. Pearson N.D., Prescott C.D. Chem. Biol. 4:1997;409.
11. Hermann T., Westhof E. Curr. Opin. Biotech. 9:1998;66.
12. Tor Y. Angew. Chem. 38:1999;1579.
13. Hermann T., Westhof E. J. Med. Chem. 42:1999;1250.
14. Wilson W.D., Li K. Curr. Med. Chem. 7:2000;73.
15. Puglisi, E. V.; Puglisi, J. D. In RNA Structure and Function; Simons, R. W. Grunberg-Manago, M., Eds, Cold Spring Harbor Press, Cold Spring Harbor 1998, p 117.
16. Lynch S.R., Recht M.I., Puglisi J.D. Meth. Enz. 317:1999;240.
17. Schroeder R., nov Ahsen U. Nucl. Acids Mol. Biol. 10:1996;53.
18. Hermann T., Westhof E. J. Mol. Biol. 276:1998;903.
19. Rogers J., Chang A.H., Ahsen U.v., Schroeder R. J. Mol. Biol. 36:1996;916.
20. Ahsen U.v., Davies J., Schroeder R. Nature. 353:1991;368.
21. Mei H.-Y., Galan A.A., Halim N.J., Mack D.P., Moreland J.W., Sanders K.B., Truong H.N., Czarnik A.J. Bioorg. Med. Chem. Lett. 5:1995;2755.
22. Wang S., Huber P.W., Cui M., Czarnik A.W., Mei H.-Y. Biochemistry. 37:1998;5549.
23. Zapp M.L., Stern S., Green M.R. Cell. 74:1993;969.
24. Rogers M.J., Bukhman Y.V., McCutchan R.F., Draper D.E. RNA. 3:1997;815.
25. Conn G.L., Gutell R.R., Draper D.E. Biochemistry. 37:1998;11980.
26. Ratmeyer L., Zapp M.L., Green M.R., Vinayak R., Kumar A., Boykin D.W., Wilson W.D. Biochemistry. 35:1996;13689.
27. Zapp M.L., Young D.W., Kumar A., Singh R., Boykin D.W., Wilson W.D., Green M.R. Bioorg. Med. Chem. 5:1997;1149.
28. Li, K.; Xiao, G.; Rigl, T.; Kumar, A.; Boykin, D. W.; Wilson, W. D. In Structure, Motion, Interaction and Expression of Biological Macromolecules; Sarma, R. H., Sarma, M. H., Eds.; Adenine: 1998; 137-145.
29. Pritchard C.E., Grasby J.A., Hamy F., Zacharek A.M., Singh M., Karn J., Gait M.J. Nucl. Acids Res. 22:1994;2592.
30. Tan R., Chen L., Buettner D.H., Frankel A.D. Cell. 73:1997;1031.
31. Peterson R.D., Bartel D.P., Szostak J.W., Horvath S.J., Feigon J. Biochemistry. 33:1994;5357.
32. Li K., Fernandex-Saiz M., Rigl C.T., Kumar A., Ragunathan K.G., McConnaughie A.W., Boykin D.W., Schneider H.-J., Wilson W.D. Bioorg. Med. Chem. 5:1997;1157.
33. Rigl C.T., Lioyd D.H., Tsou D.S., Gryaznov S.M., Wilson W.D. Biochemistry. 36:1997;650.
34. Long K.S., Crothers D.M. Biochemistry. 34:1995;8885.
35. Luedtke N.W., Tor Y. Angew. Chem. Int. Ed. 39:2000;1788.
36. Das B.P., Boykin D.W. J. Med. Chem. 20:1977;1219.
37. Bajic M., Kumar A., Boykin D.W. Heterocyclic Comm. 2:1996;135.
38. Kumar A., Boykin W.D. Syn. Commun. 25:1995;2071.
39. Kumar A., Boykin D.W., Wilson W.D. Eur. J. Med. Chem. 31:1996;767.
40. Das B.P., Wallace R.A., Boykin D.W. J. Med. Chem. 23:1980;578.
41. Wilson W.D., Tanious F.A., Fernandez-Saiz M., Rigl C.T. Methods Mol. Med. 90:1997;219.
42. Daly T.J., Doten R.C., Rennert P., Auer M., Jaksche H., Donner A., Fisk G., Rusche J.R. Biochemistry. 32:1993;10497.